ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008